1、Global Healthcare Private Equity Report 2026This work is based on secondary market research,analysis of financial information available or provided to Bain&Company and a range of interviews with industry participants.Bain&Company has not independently verified any such information provided or availa

2、ble to Bain and makes no representation or warranty,express or implied,that such information is accurate or complete.Projected market and financial information,analyses and conclusions contained herein are based on the information described above and on Bain&Companys judgment,and should not be const

3、rued as definitive forecasts or guarantees of future performance or results.The information and analysis herein does not constitute advice of any kind,is not intended to be used for investment purposes,and neither Bain&Company nor any of its subsidiaries or their respective officers,directors,shareh

4、olders,employees or agents accept any responsibility or liability with respect to the use of or reliance on any information or analysis contained in this document.This work is copyright Bain&Company and may not be published,transmitted,broadcast,copied,reproduced or reprinted in whole or in part wit

5、hout the explicit written permission of Bain&Company.Copyright 2026 Bain&Company,Inc.All rights reserved.1Global Healthcare Private Equity Report 2026ContentsHealthcare Private Equity Market 2025:Resurgence and Record Growth.2What Differentiates Winning Healthcare IT Investments .12New Models of Val

6、ue Creation for Physician Groups .18Playing the Long Game in Pharma Services .222At a Glance Despite a second-quarter tariff-related pause,global healthcare private equity activity set a record,with more than$190 billion in estimated deal value,while deal volume logged its second-best year ever.An u